Pharmagreen Biotech Inc.
PHBI
$0.0012
$0.00019.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 537.06% | -336.47% | 73.91% | 79.79% | -267.77% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,154.29% | 765.00% | -143.39% | -356.14% | 181.21% |
| Change in Net Operating Assets | 13.34% | -20.03% | -29.53% | -41.23% | -20.64% |
| Cash from Operations | -245.00% | 103.99% | -109.33% | 22.74% | 89.74% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 100.00% | -97.18% | 73.01% | -- |
| Total Debt Repaid | -- | -- | -- | -103.85% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 100.00% | -97.18% | 48.94% | -- |
| Foreign Exchange rate Adjustments | -513.33% | -104.15% | 99.27% | 22.73% | 113.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 220.00% | 100.00% | 85.71% | 98.86% | -102.96% |
